Skip to main content
Image coming soon

Mid-Market AI in Pharmaceutical R&D Operations for Compliance Officers

$199.00
Adding to cart… The item has been added

A tailored course, built for your situation

Mid-Market AI in Pharmaceutical R&D Operations for Compliance Officers

Implementation-grade strategies for compliant, auditable AI integration in mid-market pharma R&D

$199 one-time
24-hour access provisioning 30-day money-back guarantee Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
Compliance officers are expected to enable innovation while preventing risk, but generic AI training doesn’t address the specific regulatory and operational demands of mid-market pharma R&D.

The situation this course is for

Mid-market pharmaceutical companies are under pressure to innovate faster with leaner teams. As AI tools enter R&D workflows, compliance officers must assess, document, and validate their use without slowing progress. Yet most training focuses on enterprise-scale models or theoretical ethics, leaving practitioners without practical, audit-ready frameworks tailored to resource-constrained environments.

Who this is for

Compliance, quality assurance, and regulatory affairs professionals in mid-market pharmaceutical organizations who are tasked with overseeing AI adoption in R&D but lack targeted, implementation-focused guidance.

Who this is not for

Enterprise-level compliance executives with dedicated AI governance teams, or professionals outside the pharmaceutical sector seeking general AI ethics training.

What you walk away with

  • Apply AI validation frameworks aligned with FDA 21 CFR Part 11 and EU GMP Annex 11
  • Design audit-ready documentation workflows for AI-driven R&D processes
  • Evaluate AI vendor compliance posture using a structured scoring methodology
  • Implement data integrity controls specific to AI model training and inference in R&D
  • Lead cross-functional alignment between R&D, IT, and compliance on AI deployment

The 12 modules (with all 144 chapters)

Module 1. AI in Mid-Market Pharma R&D: Landscape and Compliance Imperatives
Overview of AI adoption trends, regulatory expectations, and the evolving role of compliance officers.
12 chapters in this module
  1. Defining mid-market in the pharmaceutical sector
  2. Current drivers of AI adoption in R&D
  3. Regulatory bodies and emerging AI guidance
  4. The compliance officer as innovation enabler
  5. Balancing speed and rigor in AI deployment
  6. Key differences from enterprise AI governance
  7. Common misconceptions about AI and compliance
  8. Case study: AI in preclinical data analysis
  9. Compliance touchpoints in the R&D lifecycle
  10. Mapping AI use cases to regulatory domains
  11. Stakeholder expectations across functions
  12. Preparing for internal and external audits
Module 2. Regulatory Frameworks for AI in Life Sciences
Deep dive into relevant regulations and how they apply to AI systems in R&D.
12 chapters in this module
  1. 21 CFR Part 11 and electronic records
  2. EU GMP Annex 11 alignment
  3. ICH Q9 and risk management principles
  4. Applying ALCOA+ to AI-generated data
  5. Data integrity in model training sets
  6. Validation expectations for adaptive algorithms
  7. Audit trails for AI decision logs
  8. Change control in AI model updates
  9. Supplier oversight for third-party AI tools
  10. Documentation standards for AI validation reports
  11. Regulatory inspection readiness
  12. Preparing for AI-specific audit lines of inquiry
Module 3. AI Risk Assessment and Governance Models
Structured approaches to evaluating and governing AI systems in compliance-critical environments.
12 chapters in this module
  1. Risk categorization for AI use cases
  2. Developing an AI risk scoring matrix
  3. Assigning accountability across functions
  4. Establishing AI review boards
  5. Thresholds for escalated review
  6. Risk-based documentation intensity
  7. Dynamic risk reassessment protocols
  8. Incorporating patient safety considerations
  9. Handling model drift and performance decay
  10. Defining acceptable uncertainty levels
  11. Escalation paths for non-compliant AI use
  12. Integrating AI risk into enterprise risk management
Module 4. Data Governance for AI Training and Inference
Ensuring data quality, provenance, and compliance throughout the AI lifecycle.
12 chapters in this module
  1. Sourcing compliant training data
  2. Anonymization and de-identification techniques
  3. Data lineage tracking for AI models
  4. Version control for datasets
  5. Bias detection in training data
  6. Data access controls and audit logs
  7. Retention policies for AI-related data
  8. Handling sensitive compound and trial data
  9. Cross-border data transfer considerations
  10. Data integrity checks during inference
  11. Validating data pipeline transformations
  12. Documenting data governance decisions
Module 5. Model Validation and Verification Protocols
Practical validation strategies for AI models in regulated R&D settings.
12 chapters in this module
  1. Defining validation objectives for AI systems
  2. Establishing performance benchmarks
  3. Testing for reproducibility and consistency
  4. Validation of black-box vs. interpretable models
  5. Handling probabilistic outputs in decision-making
  6. Version control for model artifacts
  7. Revalidation triggers and schedules
  8. Peer review processes for model validation
  9. Documentation templates for validation reports
  10. Incorporating clinical context into validation
  11. Validation of transfer learning applications
  12. Handling model updates and patches
Module 6. Audit Readiness and Documentation Standards
Building and maintaining audit-ready AI compliance documentation.
12 chapters in this module
  1. Essential documentation for AI systems
  2. Creating a compliance dossier for each AI tool
  3. Standard operating procedures for AI use
  4. Training records for AI system operators
  5. Maintaining audit trails for model decisions
  6. Documenting risk assessments and mitigations
  7. Version-controlled policy updates
  8. Preparing for unannounced audits
  9. Responding to auditor inquiries about AI
  10. Common findings and how to avoid them
  11. Internal audit checklists for AI compliance
  12. Continuous documentation improvement
Module 7. Vendor Management and Third-Party AI Tools
Assessing and overseeing external AI solutions used in R&D.
12 chapters in this module
  1. Evaluating vendor compliance posture
  2. Key questions for AI vendor due diligence
  3. Contractual requirements for AI tools
  4. Right-to-audit clauses for AI systems
  5. Assessing vendor model validation practices
  6. Handling proprietary algorithms and transparency
  7. Ongoing monitoring of vendor performance
  8. Incident response coordination with vendors
  9. Data ownership and exit strategies
  10. Managing multi-vendor AI ecosystems
  11. Vendor risk scoring and tiering
  12. Documentation of vendor oversight activities
Module 8. Change Control and Lifecycle Management
Managing AI system changes in a compliant, controlled manner.
12 chapters in this module
  1. Defining AI system components under change control
  2. Assessing impact of model updates
  3. Approval workflows for AI changes
  4. Testing requirements for modified systems
  5. Documentation updates for changes
  6. Handling emergency changes
  7. Version rollback procedures
  8. Change control for data pipeline updates
  9. User communication about system changes
  10. Archiving deprecated models and data
  11. Lifecycle phases for AI systems
  12. Decommissioning AI tools securely
Module 9. Cross-Functional Collaboration and Communication
Facilitating effective collaboration between compliance, R&D, and IT.
12 chapters in this module
  1. Building trust across technical and compliance teams
  2. Translating regulatory requirements for engineers
  3. Communicating risk in business terms
  4. Facilitating joint risk assessments
  5. Establishing feedback loops for AI issues
  6. Running effective AI governance meetings
  7. Creating shared glossaries and definitions
  8. Managing conflicting priorities
  9. Escalation pathways for unresolved issues
  10. Training non-compliance staff on AI controls
  11. Documenting collaboration decisions
  12. Measuring cross-functional effectiveness
Module 10. AI Ethics and Responsible Innovation
Integrating ethical considerations into AI deployment without slowing progress.
12 chapters in this module
  1. Defining responsible AI in pharma context
  2. Bias detection and mitigation strategies
  3. Ensuring fairness in AI-assisted decisions
  4. Transparency and explainability expectations
  5. Patient privacy in AI applications
  6. Handling dual-use research concerns
  7. Ethical review of AI use cases
  8. Stakeholder engagement on AI ethics
  9. Documenting ethical decision-making
  10. Balancing innovation and caution
  11. Public trust and reputational risk
  12. Ethics in AI vendor selection
Module 11. Incident Response and Non-Conformance Management
Responding to AI-related compliance incidents and deviations.
12 chapters in this module
  1. Defining AI-related non-conformances
  2. Initial response to AI system failures
  3. Investigation protocols for AI incidents
  4. Root cause analysis for model errors
  5. Corrective and preventive actions (CAPA)
  6. Reporting incidents to regulators
  7. Managing recalls involving AI decisions
  8. Communication during AI incidents
  9. Lessons learned and system improvements
  10. Documentation of incident response
  11. Testing incident response plans
  12. Proactive monitoring for early warning signs
Module 12. Scaling AI Compliance Across the Organization
Expanding AI governance practices as adoption grows.
12 chapters in this module
  1. Assessing organizational readiness for AI scale-up
  2. Developing a center of excellence for AI compliance
  3. Standardizing AI governance across projects
  4. Training programs for broader teams
  5. Metrics for AI compliance maturity
  6. Budgeting for AI governance activities
  7. Integrating AI compliance into quality systems
  8. Leadership communication about AI strategy
  9. Succession planning for AI compliance roles
  10. Benchmarking against industry peers
  11. Continuous improvement of AI governance
  12. Future-proofing compliance for next-gen AI

How this maps to your situation

  • Implementing AI in preclinical data analysis
  • Validating third-party AI tools for clinical trial design
  • Establishing governance for AI-driven compound screening
  • Preparing for regulatory audit of AI-enhanced R&D processes

Before vs. after

Before
Uncertain about how to apply compliance frameworks to AI systems, relying on ad-hoc assessments and generic guidance not tailored to mid-market pharma R&D.
After
Equipped with a structured, audit-ready approach to AI compliance, enabling confident decision-making and leadership in AI-enabled innovation.

What's included with your purchase

  • 12 modules with 12 chapters each (144 chapters)
  • Downloadable templates and worked examples for every module
  • Hand-built implementation playbook delivered alongside course access
  • 30-day money-back guarantee

Delivery and format

  • Course and learning environment access provisioned within 24 hours of purchase
  • Hand-built implementation playbook delivered alongside course access

Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.

Time investment: Approximately 45, 60 hours total, designed for flexible, self-paced completion over 6, 8 weeks.

If nothing changes
Without a structured approach, compliance officers risk either stifling innovation through excessive caution or exposing the organization to regulatory findings due to uncontrolled AI use.

How this compares to the alternatives

Unlike generic AI ethics courses or enterprise-focused governance programs, this course delivers mid-market-specific, implementation-grade knowledge with direct applicability to pharmaceutical R&D compliance challenges.

Frequently asked

Who is this course designed for?
Compliance, quality, and regulatory affairs professionals in mid-market pharmaceutical companies who are involved in overseeing AI adoption in R&D.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is this course technical or regulatory?
It bridges both domains, providing regulatory context with practical technical implementation guidance tailored to compliance professionals.
$199 one-time. Approximately 45, 60 hours total, designed for flexible, self-paced completion over 6, 8 weeks..

Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.

30-day money-back guarantee· 144 chapters· Hand-built playbook included· Account access within 24 hours
!